Home > News > Fisher HealthCare to Distribute Nanogen PCR Products
August 9th, 2006
Fisher HealthCare to Distribute Nanogen PCR Products
Abstract:
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that Fisher HealthCare, Inc., a unit of Fisher Scientific International Inc. (NYSE: FSH), will become the exclusive distributor of Nanogen's MGB Alert(TM) real-time polymerase chain reaction (PCR) products in the United States. Fisher will have exclusive rights to sell and distribute the products to clinical laboratories. The companies expect that customers will be able to access the Nanogen products through Fisher in September.
Source:
Nanogen
| Related News Press |
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||